A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorder

BACKGROUND: Major depressive disorder (MDD) is a leading cause of disability worldwide. The current treatments are ineffective in approximately one-third of patients, resulting in a large economic burden and reduced quality of life for a significant proportion of the global population. There is cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Plank, Julia R., Glover, Stephanie C., Moloney, Ben D., Hoeh, Nicholas R., Sundram, Frederick, Sumner, Rachael L., Muthukumaraswamy, Suresh, Lin, Joanne C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524133/
https://www.ncbi.nlm.nih.gov/pubmed/36175917
http://dx.doi.org/10.1186/s13063-022-06738-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524133/
https://www.ncbi.nlm.nih.gov/pubmed/36175917
http://dx.doi.org/10.1186/s13063-022-06738-3

Ejemplares similares